[Cancer Management and Research] Based on these study findings, researchers present 4 prediction models developed to determine risk of malignancy in subsolid and solid lung nodules that are 15 mm or smaller and 15 to 30 mm.
Study found adding immunotherapy to radiotherapy significantly improved OS after definitive surgery for primary tumor in patients with brain metastasis.
From 2016 to 2018, there was also an increase in daily use, sole e-cigarette use.
Immunotherapy has improved outcomes for patients with cancer, despite several drawbacks. This review provides an overview of how to manage patients undergoing therapy with these drugs.
The FDA has approved Gavreto™ (pralsetinib; Blueprint Medicines and Genentech) for the treatment of adults with metastatic RET fusion-positive NSCLC.